ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Corgi Beauty, Skincare & Aesthetics ETF
28.03
+0.2790
1.01%
盤後：
27.75
-0.2790
-1.00%
16:10 EDT
成交量：
32
成交額：
895
市值：
140.13萬
市盈率：
- -
高：
28.03
開：
27.75
低：
28.03
收：
27.75
52周最高：
29.89
52周最低：
24.32
股本：
5.00萬
流通股本：
5.00萬
量比：
0.00
換手率：
0.06%
股息：
- -
股息率：
- -
淨資產收益率：
--
總資產收益率：
--
市淨率：
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞
公告
Kenvue 宣佈：FDA 授予泰諾新非處方配方三年市場獨佔權
投资观察
·
07/25
FDA批准泰諾®與萘普生複方製劑：首款非處方對乙酰氨基酚（650毫克）與萘普生鈉（220毫克）固定劑量組合
美股速递
·
07/25
美國FDA批准非處方泰諾複方止痛片
路透中文
·
07/24
美國FDA批准首款對乙酰氨基酚/萘普生非處方組合產品——泰諾聯用萘普生，提供12小時鎮痛效果
美股速递
·
07/24
艾利科技推出全新創新成果，藉助整合型Align™數字平台提升Invisalign®治療方案規劃與患者參與度
美股速递
·
07/24
Genmab與艾伯維就Epcoritamab（Duobody®-CD3xCD20）治療復發/難治性瀰漫大B細胞淋巴瘤的3期EPCORE® DLBCL-1試驗作出澄清
美股速递
·
07/24
Genmab澄清：總生存期（OS）作為美國3期Epcore® DLBCL-1試驗的唯一主要終點，但未能達到
美股速递
·
07/24
FDA顧問委員會投票支持將Bpc-157肽納入允許藥房配製清單，Hims & Hers Health股價飆升10%
美股速递
·
07/24
FDA顧問小組投票決定將廣受歡迎的肽BPC-157列入複方製劑清單
路透中文
·
07/24
美國FDA顧問小組評估肽類限制，業界促放寬
路透中文
·
07/24
遠程醫療公司Hims & Hers力促FDA放寬部分肽類准入，股價上漲2%
美股速递
·
07/23
「司美格魯肽臉」 催生醫美熱潮？瑞士企業稱面部鬆弛風潮帶動肉毒素需求暴漲
环球市场播报
·
07/23
數據：某看跌巨鯨三天存入 3112 萬枚 USDC，空頭總倉位 6490 萬美元
链捕手
·
07/23
巴克萊上調雅詩蘭黛目標價至80美元
格隆汇
·
07/22
營收翻倍股價卻遭「膝蓋斬」，林清軒的高端護膚敍事困於流量與單品|發現好公司
时代周报
·
07/21
巴克萊上調雅詩蘭黛、可口可樂目標價
格隆汇
·
07/21
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/GLAM/news?page=7"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GLAM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLAM\",,,,,undefined,":{"symbol":"GLAM","market":"US","secType":"STK","nameCN":"Corgi Beauty, Skincare & Aesthetics ETF","latestPrice":28.0254,"timestamp":1789156800000,"preClose":27.7464,"halted":0,"volume":32,"hourTrading":{"tag":"盘后","latestPrice":27.7464,"preClose":28.0254,"latestTime":"16:10 EDT","volume":6,"amount":168.1524,"timestamp":1789157404559,"change":-0.279,"changeRate":-0.009955,"amplitude":0},"delay":0,"changeRate":0.010055358532998873,"floatShares":50000,"shares":50000,"eps":0,"marketStatus":"休市中","change":0.279,"latestTime":"09-11 16:00:00 EDT","open":27.7464,"high":28.0254,"low":28.0254,"amount":895,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"exchange":"CBOE","adjPreClose":27.7464,"nav":27.74,"aum":1387000,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":27.7464,"preClose":28.0254,"latestTime":"16:10 EDT","volume":6,"amount":168.1524,"timestamp":1789157404559,"change":-0.279,"changeRate":-0.009955,"amplitude":0},"volumeRatio":0.0031186651626592056,"impliedVol":0.5022,"impliedVolPercentile":0.6625},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLAM\",,,,,undefined,":{"symbol":"GLAM","floatShares":50000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.0031186651626592056,"shares":50000,"dividePrice":0,"high":28.0254,"amplitude":0,"preClose":27.7464,"low":28.0254,"week52Low":24.3178,"pbRate":"--","week52High":29.89,"institutionHeld":0,"latestPrice":28.0254,"eps":0,"divideRate":0,"volume":32,"delay":0,"ttmEps":0,"open":27.7464,"prevYearClose":25.82,"prevWeekClose":29.069,"prevMonthClose":28.9677,"prevQuarterClose":27.6454,"fiveDayClose":28.8959,"twentyDayClose":28.2829,"sixtyDayClose":26.38},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GLAM\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GLAM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GLAM\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GLAM\",pageSize:20,pageCount:7,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1106583056","title":"Kenvue 宣佈：FDA 授予泰諾新非處方配方三年市場獨佔權","url":"https://stock-news.laohu8.com/highlight/detail?id=1106583056","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106583056?lang=zh_tw&edition=fundamental","pubTime":"2026-07-25 02:17","pubTimestamp":1784917050,"startTime":"0","endTime":"0","summary":"7月24日——Kenvue 公司披露，美国食品药品监督管理局已正式批准泰诺与萘普生的复方制剂。这是市面上首款，也是唯一一款含有对乙酰氨基酚和萘普生钠的非处方固定剂量组合产品。不仅如此，FDA还授予了该新配方长达三年的市场独占权。这一举措，无疑为Kenvue在非处方止痛药领域的布局提供了坚实的护城河。据Kenvue方面透露，这款名为“泰诺与萘普生”的新品很快将在美国各大主要零售商上架销售。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128525929.USD","LU0310800379.SGD","RSPS","BK4183","LU0889566641.SGD","LU0708994859.HKD","KVUE","LU0792757196.USD","IE00BFXG1179.USD","LU1267930573.SGD","LU1267930813.SGD","IE00B3T34201.USD","BK4588","GLAM","BK4585","LU0029864427.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128949873","title":"FDA批准泰諾®與萘普生複方製劑：首款非處方對乙酰氨基酚（650毫克）與萘普生鈉（220毫克）固定劑量組合","url":"https://stock-news.laohu8.com/highlight/detail?id=1128949873","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128949873?lang=zh_tw&edition=fundamental","pubTime":"2026-07-25 02:01","pubTimestamp":1784916077,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）已正式批准泰诺®与萘普生复方制剂上市。这款产品是首款且唯一一款非处方固定剂量组合药物，其成分为对乙酰氨基酚（650毫克）与萘普生钠（220毫克）。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0708994859.HKD","GLAM","BK4183","LU0128525929.USD","LU0310800379.SGD","RSPS","KVUE","LU0029864427.USD","LU1267930573.SGD","IE00BFXG1179.USD","LU1267930813.SGD","IE00B3T34201.USD","LU0889566641.SGD","LU0792757196.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653035035","title":"美國FDA批准非處方泰諾複方止痛片","url":"https://stock-news.laohu8.com/highlight/detail?id=2653035035","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653035035?lang=zh_tw&edition=fundamental","pubTime":"2026-07-24 23:56","pubTimestamp":1784908596,"startTime":"0","endTime":"0","summary":"美国FDA批准非处方泰诺复方止痛片路透7月24日-美国食品和药物管理局周五批准了一种非处方固定剂量片剂，该药将Kenvue公司的KVUE.N泰诺与非甾体抗炎药萘普生结合，可提供长达12小时的止痛效果。FDA表示，此次批准符合特朗普的“伟大医疗计划”，该联邦计划旨在让更多经过验证的安全药品可供非处方购买。此前，美国卫生官员对孕期服用泰诺与自闭症之间据称存在的关联表示担忧，泰诺因此受到密切关注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260724:nL4S43Q1CZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128525929.USD","LU1430594728.SGD","LU2463526074.USD","LU1267930813.SGD","BK4588","LU0889566641.SGD","KMB","LU0708994859.HKD","KVUE","RSPS","LU0029864427.USD","IE00B3T34201.USD","BK4504","BK4585","LU1267930573.SGD","SG9999001440.SGD","LU0792757196.USD","BK4567","LU1585245621.USD","LU1571399168.USD","BK4183","IE00BFXG1179.USD","LU0310800379.SGD","BK4018","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164500582","title":"美國FDA批准首款對乙酰氨基酚/萘普生非處方組合產品——泰諾聯用萘普生，提供12小時鎮痛效果","url":"https://stock-news.laohu8.com/highlight/detail?id=1164500582","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164500582?lang=zh_tw&edition=fundamental","pubTime":"2026-07-24 22:48","pubTimestamp":1784904499,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）近日正式批准了泰诺（Tylenol）与萘普生（Naproxen）的联合用药方案。这是首款非处方（OTC）复方制剂，将对乙酰氨基酚（Acetaminophen）与萘普生（Naproxen）合二为一，专为缓解疼痛而设计，其药效可长达12小时。这一创新组合，有望为饱受疼痛困扰的患者提供更持久、更便捷的镇痛选择，无需频繁服药。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1267930573.SGD","LU0310800379.SGD","KVUE","BK4585","IE00B3T34201.USD","LU0029864427.USD","LU0708994859.HKD","LU0128525929.USD","RSPS","LU0792757196.USD","LU0889566641.SGD","BK4183","LU1267930813.SGD","GLAM","IE00BFXG1179.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108936974","title":"艾利科技推出全新創新成果，藉助整合型Align™數字平台提升Invisalign®治療方案規劃與患者參與度","url":"https://stock-news.laohu8.com/highlight/detail?id=1108936974","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108936974?lang=zh_tw&edition=fundamental","pubTime":"2026-07-24 04:43","pubTimestamp":1784839410,"startTime":"0","endTime":"0","summary":"艾利科技（Align Technology）近日宣布一系列全新创新举措。这些成果旨在进一步推动Invisalign®治疗方案规划的进步。同时，通过其整合型Align™数字平台，患者参与度也将得到显著增强。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1974910355.USD","BK4585","LU1917777945.USD","LU2023250843.SGD","GLAM","LU2106854487.HKD","BK4534","BK4588","BK4504","LU2023250504.SGD","ALGN","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135293473","title":"Genmab與艾伯維就Epcoritamab（Duobody®-CD3xCD20）治療復發/難治性瀰漫大B細胞淋巴瘤的3期EPCORE® DLBCL-1試驗作出澄清","url":"https://stock-news.laohu8.com/highlight/detail?id=1135293473","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135293473?lang=zh_tw&edition=fundamental","pubTime":"2026-07-24 04:01","pubTimestamp":1784836901,"startTime":"0","endTime":"0","summary":"Genmab与艾伯维公司（AbbVie）日前就备受关注的3期EPCORE® DLBCL-1临床试验发布了最新澄清说明。该试验旨在全面评估Epcoritamab（Duobody®-CD3xCD20）这一创新疗法在复发或难治性弥漫大B细胞淋巴瘤（DLBCL）患者中的疗效与安全性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739343.SGD","IE00BLSP4239.USD","LU0124676726.USD","LU0158827948.USD","IE0002270589.USD","IE0002141913.USD","LU1057294990.SGD","IE000BZT7R73.USD","BK4139","LU1989771016.USD","LU0965509101.SGD","LU0198837287.USD","LU0820561818.USD","LU1074936037.SGD","LU0965509010.AUD","LU1093756325.SGD","LU0170899867.USD","RXL","LU1670627923.USD","IE00BFTCPJ56.SGD","SG9999003800.SGD","LU2237443382.USD","LU0098860793.USD","LU1023059063.AUD","AGNG","FTXH","LU0795875169.SGD","LU1244550577.SGD","LU1732800096.USD","BK4581","BK4534","LU0553294199.USD","IE00BVYPNW00.USD","MEDX","TRUH","LU0432979614.USD","LU0114720955.EUR","LU0511384066.AUD","LU1551013342.USD","LU2237443895.HKD","LU0708994859.HKD","LU0868494708.USD","LU1934455863.HKD","LU1291159041.SGD","LU1496350502.SGD","LU0234572021.USD","IE00BN8TJ469.HKD","IE00B19Z3581.USD","LU0289961442.SGD","LU1983299246.USD","LU0795875086.SGD","LU1267930573.SGD","JDOC","IE000SO60NU8.SGD","LU1162221912.USD","LU2089283258.USD","LU1585245621.USD","LU2237443978.SGD","LU0211328371.USD","LU0738911758.USD","LU0868494617.USD","LU2357627491.SGD","LU2237443622.USD","LU0942090050.USD","LU2129689605.HKD","LU0965508806.USD","LU2087621335.USD","LU1037948897.HKD","LU1430594728.SGD","LU2023251221.USD","LU2237443549.SGD","LU0203345920.USD","LU2129689514.USD","LU1989772840.SGD","LU1003077747.HKD","XLV","LU1093756168.USD","LU2433249047.HKD","SG9999015978.USD","BK4550","LU0289739699.SGD","BK4559","IE0000B7K699.USD","IE00B42XCP33.USD","LU0029864427.USD","LU0058720904.USD","LU0203347892.USD","IE00BVYPNV92.GBP","IE00BGHQF631.EUR","LU0661504455.SGD","SG9999011175.SGD","LU0211327993.USD","LU0234570918.USD","IE000WAW04H5.SGD","IE00B19Z3B42.SGD","IXJ","LU0943347566.SGD","LU1670628061.USD","LU1934455194.USD","SG9999015986.USD","LU2347655156.SGD","LU1934455277.USD","LU1061106388.HKD","LU0472753341.HKD","LU1989772923.USD","LU0057025933.USD","LU0820561909.HKD","VHT","LU0069063385.USD","LU0985320562.USD","LU0861579265.USD","SG9999001440.SGD","LU2089984988.USD","BK4585","IE0009355771.USD","IE00BJT1NW94.SGD","LU0949170772.SGD","LU2125909247.SGD","IE00B2B36J28.USD","LU0823416689.USD","LU0320765646.SGD","IE0004445239.USD","LU2133065610.SGD","LU0859254822.USD","BK4566","LU1267930490.SGD","IE00BDGV0183.EUR","LU1244550494.USD","IE00B3PB1722.GBP","IYH","BK4533","LU0122379950.USD","LU2129689431.USD","LU1244550221.USD","PPH","IE000MB6IJN5.SGD","LU1929549753.HKD","LU2089284900.SGD","LU2237443465.HKD","LU0128525929.USD","LU1718418525.SGD","LU2125909593.SGD","LU0417517546.SGD","PJP","IE000F7OJYX1.SGD","LU0689472784.USD","LU2468319806.SGD","SG9999015945.SGD","LU0456855351.SGD","LU0689626769.HKD","IE00BSNM7G36.USD","LU0310800379.SGD","LU0912757837.SGD","IE00BBT3K403.USD","LU1551013425.SGD","LU2112291526.USD","IE00B4R5TH58.HKD","LU0310799852.SGD","LU0545039389.USD","LU1037948541.HKD","ABBV","IE00BLSP4452.SGD","SG9999015952.SGD","FHLC","IE00BJJMRZ35.SGD","LU0256863902.USD","LU0256863811.USD","GLAM","LU0965509283.SGD","LU1923622614.USD","LU0882574055.USD","LU1496350171.SGD","LU1732799900.SGD","BK4588","LU1839511570.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116716506","title":"Genmab澄清：總生存期（OS）作為美國3期Epcore® DLBCL-1試驗的唯一主要終點，但未能達到","url":"https://stock-news.laohu8.com/highlight/detail?id=1116716506","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116716506?lang=zh_tw&edition=fundamental","pubTime":"2026-07-24 04:01","pubTimestamp":1784836871,"startTime":"0","endTime":"0","summary":"Genmab公司近日发布声明，对关于其3期Epcore® DLBCL-1临床试验的结果进行了进一步澄清。该公司明确指出，总生存期（OS）是此项试验在美国设定的唯一主要终点。然而，令人遗憾的是，这一关键终点最终并未能成功达到。\n此声明旨在厘清外界对试验数据的理解，避免不必要的误读。总生存期作为衡量患者从治疗开始到死亡时间的最直接指标，其未达到预期结果，对Genmab而言无疑是一个重大挫折。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0211328371.USD","IE000F7OJYX1.SGD","BK4559","LU2237443465.HKD","FTXH","IE00BN8TJ469.HKD","BK4534","LU1093756168.USD","LU2125909247.SGD","LU0310799852.SGD","LU0965508806.USD","LU1162221912.USD","SG9999015945.SGD","LU1057294990.SGD","LU0820561818.USD","IE00B2B36J28.USD","LU2089284900.SGD","LU1074936037.SGD","LU1989772923.USD","LU2237443382.USD","LU1037948541.HKD","LU0069063385.USD","IE00BBT3K403.USD","IE0000B7K699.USD","LU0058720904.USD","LU2125909593.SGD","LU2089984988.USD","LU1839511570.USD","IE0002141913.USD","LU1732799900.SGD","LU2133065610.SGD","LU0882574055.USD","ABBV","IE00BLSP4452.SGD","LU0029864427.USD","IE00BVYPNW00.USD","XLV","LU0057025933.USD","IE0004445239.USD","LU0965509010.AUD","LU1983299246.USD","LU0158827948.USD","LU0417517546.SGD","LU1496350171.SGD","LU0289739343.SGD","LU1267930490.SGD","IE00BVYPNV92.GBP","LU0689626769.HKD","AGNG","LU0289961442.SGD","JDOC","LU0545039389.USD","LU1003077747.HKD","LU2237443895.HKD","LU0795875169.SGD","LU1929549753.HKD","LU1718418525.SGD","BK4588","TRUH","IE0002270589.USD","LU0310800379.SGD","LU1923622614.USD","LU0912757837.SGD","IE0009355771.USD","IE000WAW04H5.SGD","LU0128525929.USD","LU0985320562.USD","IE00BJJMRZ35.SGD","IE000BZT7R73.USD","IE00B4R5TH58.HKD","LU2433249047.HKD","LU0965509283.SGD","LU0965509101.SGD","RXL","PJP","IE00BGHQF631.EUR","LU1989772840.SGD","IE000SO60NU8.SGD","LU1934455194.USD","LU1496350502.SGD","IE00BLSP4239.USD","LU0203345920.USD","LU0211327993.USD","IE00BSNM7G36.USD","BK4550","LU0456855351.SGD","LU1989771016.USD","BK4566","SG9999015978.USD","BK4581","LU1732800096.USD","LU1291159041.SGD","LU1551013342.USD","LU2129689431.USD","IE00BJT1NW94.SGD","LU0861579265.USD","LU2347655156.SGD","LU0432979614.USD","LU0820561909.HKD","BK4585","GLAM","VHT","LU1934455277.USD","LU1244550221.USD","LU0198837287.USD","LU1934455863.HKD","LU0795875086.SGD","SG9999015952.SGD","LU1244550577.SGD","LU1093756325.SGD","LU0868494708.USD","LU0942090050.USD","LU1670628061.USD","LU2087621335.USD","LU2357627491.SGD","LU2089283258.USD","FHLC","IE00BDGV0183.EUR","LU1061106388.HKD","LU0708994859.HKD","MEDX","LU2237443549.SGD","SG9999001440.SGD","LU0823416689.USD","IE00B42XCP33.USD","IXJ","LU0098860793.USD","LU2112291526.USD","LU1023059063.AUD","LU0234570918.USD","LU2237443978.SGD","LU0689472784.USD","BK4139","LU1585245621.USD","LU2129689514.USD","SG9999003800.SGD","LU0943347566.SGD","LU0170899867.USD","SG9999011175.SGD","LU0472753341.HKD","LU0114720955.EUR","LU0122379950.USD","LU1430594728.SGD","BK4533","LU0859254822.USD","LU0203347892.USD","LU1267930573.SGD","LU2468319806.SGD","PPH","LU0511384066.AUD","LU2129689605.HKD","LU0661504455.SGD","IE00B19Z3B42.SGD","LU0234572021.USD","IYH","LU0256863811.USD","IE00B3PB1722.GBP","IE00BFTCPJ56.SGD","LU0738911758.USD","LU0868494617.USD","LU0553294199.USD","IE00B19Z3581.USD","LU0949170772.SGD","LU0289739699.SGD","LU1551013425.SGD","IE000MB6IJN5.SGD","LU1244550494.USD","LU0256863902.USD","LU0124676726.USD","SG9999015986.USD","LU0320765646.SGD","LU2023251221.USD","LU1670627923.USD","LU1037948897.HKD","LU2237443622.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109432677","title":"FDA顧問委員會投票支持將Bpc-157肽納入允許藥房配製清單，Hims & Hers Health股價飆升10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1109432677","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109432677?lang=zh_tw&edition=fundamental","pubTime":"2026-07-24 00:51","pubTimestamp":1784825499,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc.股价上涨10%。这一涨势的催化剂是什么？FDA顾问委员会刚刚投票决定，将Bpc-157肽列入允许药房配制的清单中。该决定一经公布，市场随即作出强烈反应。投资者普遍认为，此举将为相关公司开辟新的业务增长路径。Bpc-157作为一种备受关注的肽类物质，如今获得监管层面的积极信号，无疑让市场情绪瞬间高涨。从消息公布到股价反应，整个过程可谓迅速而剧烈，显示出投资者对该领域前景的高度期待。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HEAL","HIYY","BK4196","HMYY","HIMS","THNR","HIMZ","HIMY","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653837722","title":"FDA顧問小組投票決定將廣受歡迎的肽BPC-157列入複方製劑清單","url":"https://stock-news.laohu8.com/highlight/detail?id=2653837722","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653837722?lang=zh_tw&edition=fundamental","pubTime":"2026-07-24 00:43","pubTimestamp":1784824996,"startTime":"0","endTime":"0","summary":"FDA顾问小组投票决定将广受欢迎的肽BPC-157列入复方制剂清单路透7月23日-美国食品和药物管理局（FDA）的一个顾问小组周四投票决定，将一种名为BPC-157的广泛使用的肽列入允许药房进行更广泛配制的清单。八名委员会成员投了赞成票，六名成员投了反对票，一名成员弃权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nL4T43P263:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMZ","GLAM","HIYY","HIMS","HMYY","BK4196","HEAL","THNR","HIMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653724664","title":"美國FDA顧問小組評估肽類限制，業界促放寬","url":"https://stock-news.laohu8.com/highlight/detail?id=2653724664","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653724664?lang=zh_tw&edition=fundamental","pubTime":"2026-07-24 00:09","pubTimestamp":1784822960,"startTime":"0","endTime":"0","summary":"拜登政府于2023年发现近20种肽类药物存在安全隐患，并禁止其合法配制。FDA 敦促开展临床试验目前已有许多肽类药物获得了卫生监管机构的批准。而此次会议中正在评估的药物尚未经过此类临床试验，且可在网上轻易购买，无需任何医生监督。FDA的评审人员上个月在文件中曾向专家小组建议，该机构不应支持允许持有州执照的配制药房进行此类操作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nL4S43P23A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","HIMS","HMYY","THNR","HEAL","HIYY","GLAM","HIMZ","HIMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159771566","title":"遠程醫療公司Hims & Hers力促FDA放寬部分肽類准入，股價上漲2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1159771566","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159771566?lang=zh_tw&edition=fundamental","pubTime":"2026-07-23 22:32","pubTimestamp":1784817171,"startTime":"0","endTime":"0","summary":"在小组会议中，远程医疗企业Hims & Hers Health Inc.（股票代码：HIMS）积极呼吁美国食品药品监督管理局（FDA）扩大对特定肽类药物的可及性。这一消息传出后，该公司股价应声上扬，涨幅达到2%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLAM","HIMY","HMYY","HIMZ","HIYY","HEAL","BK4196","HIMS","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653268147","title":"「司美格魯肽臉」 催生醫美熱潮？瑞士企業稱面部鬆弛風潮帶動肉毒素需求暴漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2653268147","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653268147?lang=zh_tw&edition=fundamental","pubTime":"2026-07-23 22:03","pubTimestamp":1784815380,"startTime":"0","endTime":"0","summary":" 高德美首席执行官弗莱明恩斯科夫周四接受 采访表示，越来越多人使用 GLP1 类减重药，推动高德美医美板块营收大幅增长。 目前约 10% 的美国成年人自述在使用 GLP1 药物减重，这类人群催生玻尿酸填充、抗皱针等医美项目需求上涨。 医美企业高德美首席执行官周四向 表示，减重药普及浪潮为公司带来重大发展机遇。 这家瑞士上市企业的股价在午盘交易中波动极小。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-07-23/doc-iniivayy4636458.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653790111","title":"數據：某看跌巨鯨三天存入 3112 萬枚 USDC，空頭總倉位 6490 萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2653790111","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653790111?lang=zh_tw&edition=fundamental","pubTime":"2026-07-23 09:49","pubTimestamp":1784771394,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，据 Onchain Lens 监测，一名看跌巨鲸在过去 3 天内向 Hyperliquid 存入 3,112 万枚 USDC，目前持有 6,490 万美元空头仓位。最新一笔存款为 512 万枚 USDC。当前仓位包括 4,393 万美元 SKHX 空头、1,707 万美元 BRENTOIL 空头，以及 SMSN、HIMS 和 NVDA 的空头仓位，钱包 100% 为空头。 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2277770","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0957808578.USD","LU0256863902.USD","LU2357125470.USD","FAI","LU1951198990.SGD","LU1720051108.HKD","LU0708994859.HKD","LU2237438978.USD","LU2271345857.HKD","LU2491049909.HKD","SG9999014898.SGD","LU0345770993.USD","SG9999017495.SGD","LU0353189763.USD","LU1064131342.USD","IE00BKVL7J92.USD","NVDS","AGOX","LU1645745479.HKD","LU2361044949.HKD","LU2237957811.SGD","LU0289739343.SGD","LU2087621335.USD","BK4608","LU0238689110.USD","LU1988902786.USD","SG9999001424.SGD","LU0133085943.USD","LU1917777945.USD","EFIV","LU0234570918.USD","LU0494093205.USD","LU1989772840.SGD","IE0004091025.USD","LU0124676726.USD","LU1153585028.USD","LU1244550221.USD","LU1670756490.USD","LU3102509885.SGD","LU0642271901.SGD","LU2462157665.USD","IE00BK4W5L77.USD","GAMR","SG9999002224.SGD","IE0004445239.USD","IE0004445015.USD","HMYY","SGXZ51526630.SGD","LU1202635105.USD","BK4551","THMR","LU0316494557.USD","LU0738911758.USD","LU0274383776.USD","LU2265009873.SGD","LU1267930730.SGD","LU2756315664.SGD","LU0096364046.USD","LU1316542783.SGD","LU2065171402.SGD","LU1116320901.HKD","LU0889565833.HKD","BK4532","CLSE","LU0106261372.USD","LU1923622291.USD","TTEQ","LU2089985449.USD","LU2125154935.USD","LU0289960550.SGD","IE00B1XK9C88.USD","LU2592432038.USD","IE0034235295.USD","HYNX","IE00BFSS7M15.SGD","IE00B4JS1V06.HKD","LU1934455863.HKD","IE0001KFT4U8.USD","LU1839511570.USD","IE000ITXATA3.USD","SMH","BK4548","LU0082616367.USD","LU0787776722.HKD","IE00BJJMRX11.SGD","LU0081259029.USD","LU2106854487.HKD","ESUM","LU0210536198.USD","LU2237443549.SGD","LU0265550359.USD","LU2065169927.USD","BK4585","LU1429558221.USD","LU2236285917.USD","LU1267930573.SGD","LU0203202063.USD","LU0006306889.USD","FDTX","3NVD.UK","LU2168564065.EUR","SHOC","LU1127390331.HKD","LU2543165471.USD","ARTY","LU2458330169.SGD","LU2213496289.HKD","HK0000914660.USD","SKHZ","LU0345768740.USD","LU0080751232.USD","LU1861215975.USD","BK4605","SG9999015978.USD","LU2471134879.HKD","LU0323239441.USD","LU2092937148.SGD","IE00BDCRKT87.USD","IE00BHPRN162.USD","IE000YTNTUN2.SGD","LU0158827948.USD","IE00BQXX3C00.GBP","LU2168564222.USD","LU1791710400.SGD","LU0965508806.USD","IE000W1ABFV2.USD","LU0965509283.SGD","LU2360032135.SGD","WISE","SKHX","LU2931357623.SGD","IE000Q6AESB8.SGD","LU0077335932.USD","HK0000320223.HKD","LU2381873111.SGD","LU1084165304.USD","SGXZ31699556.SGD","LU0203201768.USD","IE00BFSS8Q28.SGD","LU2413666426.HKD","SKHU","LU1037948897.HKD","LU2552382058.USD","LU0211328371.USD","LU1989764748.USD","BK4554","LU0708995401.HKD","CHAT","LU0094547139.USD","LU1551013425.SGD","LU0820561909.HKD","NVDU","BK4529","LFGY","LU0345769128.USD","NVD","LU0154236417.USD","LU1280957306.USD","DIPS","LU0109392836.USD","LU1815333072.USD","GLAM","LU2023250330.USD","LU2111349929.HKD","LU1066051225.USD","LU1267930490.SGD","LU1037948541.HKD","LU0868494617.USD","LU2602419157.SGD","LU0528227936.USD","HIMY","LU2249611893.SGD","SNPE","LU0170899867.USD","LU2125909593.SGD","BK4141","LU2125154778.USD","LU0672654240.SGD","IE00BJTD4V19.USD","LU0985320562.USD","LU1935042991.SGD","LU0198837287.USD","SPTE","LU0096362180.USD","LU1244550494.USD","NVII","LU0069063385.USD","LU2247934214.USD","IE00BMPRXR70.SGD","LU2750360997.AUD","IE00BK4W5M84.HKD","CMAG","LU2237443895.HKD","NVD3.UK","HK0000320264.USD","LU2360107168.USD","IE00BWXC8680.SGD","LU0511384066.AUD","LU1066051498.USD","LU2471134523.USD","SG9999014880.SGD","LU2089284900.SGD","IETC","LU2896262040.SGD","LU1983260115.SGD","BK4567","LU0109391861.USD","LU1974910355.USD","HK0000304797.USD","IE00B4YYXB79.USD","BK4534","LU0215105999.USD","METV","LU0965509101.SGD","NVDG","LU0820561818.USD","LU0011850046.USD","LU0719512351.SGD","LU2272731600.USD","LU2461242641.AUD","LU2463028550.USD","LU0061474960.USD","LU0949170772.SGD","SG9999015945.SGD","XLK","LU2471134952.CNY","IE00BQXX3D17.EUR","BK4543","IE00BKPKM429.USD","SG9999000418.SGD","LU1951200564.SGD","LU2272731782.SGD","SG9999018865.SGD","LU0965509010.AUD","SG9999004303.SGD","LU0210528500.USD","SKHY","SG9999015986.USD","LU1366333091.USD","LU2125909759.SGD","LU1435385759.SGD","LU0788109477.HKD","USXF","LU1642822529.SGD","IE00BD6J9T35.USD","LU2637965513.SGD","LU2357305700.SGD","IE0004086264.USD","LU0310800379.SGD","NVDY","LU1791710582.SGD","LU0210533765.USD","IE00B7KXQ091.USD","LU0557290698.USD","HEAL","LU0689626769.HKD","LU0143551892.USD","LU1066053197.SGD","BK4549","NVDO","SOXX","LU1778281490.HKD","BK4614","LU1814569148.SGD","TRFK","IE00BQXX3F31.USD","LU1242518931.SGD","LU0444973449.USD","LU2491050071.SGD","LU2756315318.SGD","LU2237443465.HKD","LU2413666699.HKD","LU2290526834.HKD","LU0256863811.USD","LU1261432733.SGD","NVDS.UK","LU0345769631.USD","BK4527","BK4598","LU1935042215.USD","NULC","IE00B775SV38.USD","LU1989772923.USD","LU0345768153.USD","LU2092627202.USD","LU0320765059.SGD","SGXZ81514606.USD","IE00B19Z8W00.USD","LU0048584097.USD","LU1119994496.HKD","LU0056508442.USD","LU1992135472.HKD","LU1721428933.USD","LU2286300806.USD","SG9999015952.SGD","LU1821325948.USD","LU2148611432.USD","LU2750360641.GBP","LU0323240290.USD","LU0444971666.USD","LU0354030511.USD","LU0061475181.USD","SKDD","LU2237443978.SGD","LU0979878070.USD","LU0353189680.USD","LU1571399168.USD","NVIW.SI","IE0034235188.USD","LU2063271972.USD","LU1718418525.SGD","LU1923623000.USD","LU2100268510.USD","LU2168564149.EUR","IE000KEQY171.SGD","LU1232071149.USD","LU0289961442.SGD","LU0072462426.USD","LU1244550577.SGD","LU2065170008.USD","HK0000914686.HKD","IE00B5949003.HKD","LU2458330243.SGD","IE0005OL40V9.USD","LU0266013472.USD","LU0310799852.SGD","ESLG","LU1323610961.USD","LU1712237335.SGD","ANV","LU2322448791.USD","ILDR","LU1003077747.HKD","LU1366192091.USD","LU1880398554.USD","NVDQ","LU1868836757.USD","SG9999014914.USD","LU2237443622.USD","LU0251132253.USD","LU1880398471.USD","IE0003U64NQ7.SGD","LU2294711713.HKD","BK4196","LU1035773651.USD","HIMZ","LU1720051017.SGD","VGT","IE00B19Z9505.USD","IE0034235303.USD","2NVD.UK","LU2250418816.HKD","IXN","TEK","BK4581","SG9999014542.SGD","USDC","07788","LU0138981039.USD","NVDX","IE00BKDWB100.SGD","LU1992135399.USD","LU2505996681.GBP","LU1066051811.HKD","LU2108987350.USD","HIMS","LU1804176565.USD","LU0234572021.USD","LU1674673691.USD","LU2433249047.HKD","LU2023250504.SGD","LU2237957902.USD","LU0689472784.USD","AIFD","LU1803068979.SGD","IE00B1BXHZ80.USD","LU0061474705.USD","IE0009G5SDU7.USD","LU2133065610.SGD","07388","LU1400636574.HKD","IE00BZ199S13.USD","TTXU","LU2999663052.SGD","LU0265550946.USD","SG9999015341.SGD","LU1868836914.USD","LU2954938101.SGD","NVYY","LU0943347566.SGD","SG9999014559.SGD","LU1623119135.USD","LU1935043536.SGD","LU2430703178.SGD","LU0823414478.USD","LU2191332357.HKD","LU2360106780.USD","LU1868837136.USD","THNR","07709","BK4503","LU2361045086.USD","LU1035775433.USD","LU1674673428.USD","LU0323591593.USD","LU1116320737.USD","LU1923622614.USD","HK0000532082.HKD","BK4579","LU1633808545.USD","LU2746668974.SGD","IE00B3S45H60.SGD","LU0158827781.USD","SKUU","LU1989764664.SGD","LU0107464264.USD","LU0348723411.USD","LU1815336760.USD","LU1551013342.USD","IE00B775H168.HKD","LU2430703251.USD","LU0267386448.USD","LU1069347547.HKD","IE00BN29S564.USD","LU0029864427.USD","LU1496350502.SGD","LU2279689827.SGD","LU0466842654.USD","SGXZ99366536.SGD","SG9999014906.USD","LU0211327993.USD","LU0957791311.USD","CNEQ","LU1400636657.SGD","SOXQ","BK4612","HK0000306701.USD","LU0354030438.USD","LU2272731865.HKD","LU0417517546.SGD","HK0000819398.USD","LU2083900584.USD","LU1691799644.USD","LU1934455194.USD","IE00B19Z8X17.USD","LU2065171311.SGD","HK0000306685.HKD","SOXY","LU2264538146.SGD","BK4587","LU2125909916.SGD","LU0964807845.USD","LU2746668461.USD","LU0308772762.SGD","IE00B3M56506.USD","LU2211815571.USD","LU0823421333.USD","LU1934455277.USD","LU0345770308.USD","LU2023251221.USD","LU0683600562.USD","LU2506951792.HKD","SG9999018857.SGD","LU1699723380.USD","LU1868837300.USD","LU2168564495.EUR","LU2505996509.AUD","NVDB","TYLG","LU0868494708.USD","LU2491050154.USD","LU0127658192.USD","LU1861220033.SGD","LU2394011477.USD","GB00BDT5M118.USD","IE00BMPRXN33.USD","LU1242518857.USD","VT","LU0820562030.AUD","SMHX","LU0786609619.USD","LU0157215616.USD","LU0097036916.USD","LU2089283258.USD","LU0724617625.USD","LU2473716301.USD","LU0187121727.USD","SG9999002232.USD","LU2462591277.SGD","LU0545039389.USD","LU2417539215.USD","LU1400636491.USD","AIPI","SG9999014575.USD","SG9999015358.SGD","IE00BZ1G4Q59.USD","LU2552382215.SGD","LU0640476718.USD","LU1145028129.USD","LU2077746001.SGD","HIYY","SK","LU0861579265.USD","IE00BMPRXQ63.HKD","IE00BJJMRY28.SGD","LU2403377893.USD","NVD2.UK","IE00BJLML261.HKD","LU2047632596.USD","LU0174119429.USD","FTEC","LU0053666078.USD","LU0070217475.USD","LU0390134368.USD","IE00B3SWFQ91.USD","USD","LU0882574139.USD","LU2456880835.USD","LU2242649171.HKD","LU0128525929.USD","LU0057025933.USD","LU0472753341.HKD","LU1069344957.HKD","IE00BJTD4N35.SGD","LU2471134796.USD","LU0276348264.USD","LU1861127337.USD","ROM","LU2361044865.SGD","LU0347712357.USD","LU2097344357.USD","IE00BYXW3230.USD","LU2462591350.SGD","IE0009356076.USD","ABFL","BK4533","LU1852331112.SGD","NVDD","LU2168563687.JPY","SG9999014567.USD","LU0342679015.USD","LU1548497426.USD","LU2552382132.HKD","SNVD.UK","LU2322448957.HKD","BK4550","CHPX","HK0000304805.HKD","NVDW","LU1914381329.SGD","LU0175139822.USD","LU0553294199.USD","LU0823434740.USD","LU2087625088.SGD","LU2244417387.USD","LU1935043023.USD","LU2326559502.SGD","LU0823421416.USD","LU2237443382.USD","LU2420271590.USD","LU2097344431.USD","LU2430703095.HKD","LU0823434583.USD","LU0225283273.USD","IE00BDRTCR15.USD","LU2452424414.USD","NVDL","LU1935042488.USD","LU0079474960.USD","LU2860962120.EUR","LU0942090050.USD","LU2028103732.USD","LU2054465674.USD","LU2487616109.SGD","LU0476273544.USD","LU2242650005.HKD","LU1629891620.HKD","BK4592","LU2125909247.SGD","SGXZ23171101.USD","LU0661504455.SGD","LU0823414551.USD","LU1496350171.SGD","LU1868836591.USD","NVDA","JGRO","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653012758","title":"巴克萊上調雅詩蘭黛目標價至80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2653012758","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653012758?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 16:38","pubTimestamp":1784709507,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4585","UDN","LU0690374615.EUR","LU2552382132.HKD","LU2404859667.USD","LU1988902786.USD","BK4548","BK4533","LU0690374961.EUR","UUP","LU2404859741.USD","BK4558","LU2552382058.USD","BK4183","LU1064131342.USD","LU2552382215.SGD","LU2264538146.SGD","BK4504","BK4588","GLAM","EL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653011802","title":"營收翻倍股價卻遭「膝蓋斬」，林清軒的高端護膚敍事困於流量與單品|發現好公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2653011802","media":"时代周报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653011802?lang=zh_tw&edition=fundamental","pubTime":"2026-07-21 23:52","pubTimestamp":1784649135,"startTime":"0","endTime":"0","summary":"顶着“中国高端护肤第一股”光环的林清轩（02657.HK），2025年交出了首份营收翻倍、净利增逾九成的年报。82%的毛利率将欧莱雅、雅诗兰黛等国际巨头甩在身后，24.5亿元的营收规模也创下品牌成立以来的历史峰值。然而，资本市场却给出了截然相反的回应。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607213816060486.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607213816060486.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02657","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653842276","title":"巴克萊上調雅詩蘭黛、可口可樂目標價","url":"https://stock-news.laohu8.com/highlight/detail?id=2653842276","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653842276?lang=zh_tw&edition=fundamental","pubTime":"2026-07-21 18:14","pubTimestamp":1784628866,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0738911758.USD","LU1116320737.USD","SG9999004303.SGD","BK4504","XLP","BREW","UGE","IE00BVYPNW00.USD","LU1815333072.USD","IE00BDGV0183.EUR","LU2108987350.USD","LU2552382132.HKD","LU0175139822.USD","LU0823417653.USD","KO","BK4177","TRUO","LU1732799900.SGD","LU0320765646.SGD","BK4585","FTXG","LU1116320901.HKD","LU2361044865.SGD","SG9999015358.SGD","LU2237443895.HKD","LU0950375773.USD","BK4534","LU0234570918.USD","LU2552382215.SGD","SG9999003800.SGD","BK4559","LU1032955483.USD","LU2552382058.USD","LU0823417737.USD","LU2360032135.SGD","FSTA","IE00BBT3K403.USD","LU1221951129.SGD","LU1670711040.USD","LU2506951875.HKD","LU2361044949.HKD","LU0690374961.EUR","IE00BLSP4452.SGD","BK4558","LU1868837300.USD","IE00B42XCP33.USD","IE00BVYPNV92.GBP","LU2237443622.USD","BK4610","LU2097829019.USD","LU2506951958.HKD","GLAM","IE00B3PB1722.GBP","SG9999014575.USD","LU1868836591.USD","LU2361045086.USD","LU2404859741.USD","LU1732800096.USD","LU1670710661.SGD","LU0661504455.SGD","LU0912757837.SGD","LU0957791311.USD","LU2347655156.SGD","LU1003077747.HKD","LU1670711123.USD","LU0096364046.USD","SG9999014542.SGD","LU1894683264.USD","LU2506952097.USD","LU2133065610.SGD","LU2237443465.HKD","LU2125154778.USD","LU1894683348.USD","IE00BLSP4239.USD","LU0098860793.USD","LU0545039389.USD","LU1032466523.USD","LU0265550946.USD","LU2237443978.SGD","LU0265550359.USD","LU1196500208.SGD","LU0795875169.SGD","LU0323591593.USD","LU1064131342.USD","BK4532","LU2242646235.USD","LU0289960550.SGD","LU0795875086.SGD","BK4588","SG9999002232.USD","LU0106261372.USD","PBJ","LU0061475181.USD","LU2237957811.SGD","LU2506952170.USD","LU1988902786.USD","SG9999014559.SGD","EL","LU1162221912.USD","LU0949170772.SGD","BK4533","LU2125154935.USD","LU2237443549.SGD","SG9999002224.SGD","LU0868494617.USD","LU1059921491.USD","LU1920062954.HKD","LU2401740654.USD","LU2404859667.USD","BK4183","IE00BGHQF631.EUR","LU0061474960.USD","LU0225283273.USD","LU2237957902.USD","LU1920063259.USD","LU2461242641.AUD","BK4548","LU1868837136.USD","LU1718418525.SGD","LU0234572021.USD","SGXZ23171101.USD","LU0690374615.EUR","LU2279689827.SGD","LU0006306889.USD","SG9999011175.SGD","SG9999014567.USD","LU2242646821.SGD","LU2264538146.SGD","LU1868836914.USD","IE00BN8TJ469.HKD","SG9999015341.SGD","LU1670710588.SGD","BK4581","LU1868836757.USD","LU2237443382.USD","LU2242652126.USD","LU0553294199.USD","LU1221951046.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":7,"totalSize":136,"code":"91000000","status":"200"}]}}